MY148121A - Sesamin / episesamin compositions - Google Patents

Sesamin / episesamin compositions

Info

Publication number
MY148121A
MY148121A MYPI20056238A MYPI20056238A MY148121A MY 148121 A MY148121 A MY 148121A MY PI20056238 A MYPI20056238 A MY PI20056238A MY PI20056238 A MYPI20056238 A MY PI20056238A MY 148121 A MY148121 A MY 148121A
Authority
MY
Malaysia
Prior art keywords
sesamin
episesamin
compositions
incorporated
weight ratios
Prior art date
Application number
MYPI20056238A
Other languages
English (en)
Inventor
Yoshiko Ono
Namino Tomimori
Saki Tokuda
Tomohiro Rogi
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of MY148121A publication Critical patent/MY148121A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/116—Heterocyclic compounds
    • A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C15/00—Butter; Butter preparations; Making thereof
    • A23C15/12—Butter preparations
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/111—Aromatic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
MYPI20056238A 2004-12-28 2005-12-28 Sesamin / episesamin compositions MY148121A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004381726 2004-12-28
JP2004381806 2004-12-28

Publications (1)

Publication Number Publication Date
MY148121A true MY148121A (en) 2013-02-28

Family

ID=36614967

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20056238A MY148121A (en) 2004-12-28 2005-12-28 Sesamin / episesamin compositions

Country Status (11)

Country Link
US (1) US20080275110A1 (OSRAM)
EP (1) EP1842540A4 (OSRAM)
JP (1) JP4995567B2 (OSRAM)
KR (1) KR101244586B1 (OSRAM)
CN (2) CN101849935B (OSRAM)
AU (1) AU2005320579B2 (OSRAM)
CA (1) CA2592532C (OSRAM)
MY (1) MY148121A (OSRAM)
SG (1) SG158183A1 (OSRAM)
TW (1) TW200633696A (OSRAM)
WO (1) WO2006070856A1 (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8685455B2 (en) 2005-03-31 2014-04-01 Suntory Holdings Limited Oil-in-water emulsions containing lignan-class compounds and compositions containing the same
EP1930333B1 (en) * 2005-09-30 2014-11-05 Suntory Holdings Limited Method and apparatus for producing episesamin-rich composition
RU2408598C2 (ru) * 2005-09-30 2011-01-10 Сантори Холдингз Лимитед Способ и устройство для получения композиций, обогащенных эписезамином
CN101404996B (zh) 2006-03-31 2011-05-18 三得利控股株式会社 含有木脂素类化合物的组合物
JP5409989B2 (ja) * 2006-04-03 2014-02-05 サントリーホールディングス株式会社 セサミン類含有動物用飲食物
KR101425241B1 (ko) * 2006-10-04 2014-08-01 산토리 홀딩스 가부시키가이샤 리그난류 화합물 함유 ｏ/ｗ/ｏ형 에멀션 및 그것을 함유하는 조성물
JP5276316B2 (ja) * 2007-12-28 2013-08-28 サントリーホールディングス株式会社 セサミン類及びケルセチン配糖体を含有する組成物
CN101342148B (zh) * 2008-07-03 2012-09-05 姚英 一种速效抗菌消炎、抗病毒的超浓缩天然蒜素片及其制备方法
JP5547891B2 (ja) * 2008-12-26 2014-07-16 サントリーホールディングス株式会社 セサミン類とエピガロカテキンガレートとを含有する組成物
CN104394864B (zh) * 2012-06-14 2016-10-05 三得利控股株式会社 含有芝麻素类、γ-谷维素和米胚芽油的组合物
JP2015140315A (ja) * 2014-01-29 2015-08-03 中日本カプセル 株式会社 ソフトカプセル用の充填組成物
CN107405329B (zh) * 2015-03-23 2021-04-09 三得利控股株式会社 昼夜节律改善用组合物
WO2021065664A1 (ja) * 2019-10-04 2021-04-08 サントリーホールディングス株式会社 生活活動量の維持、低下予防、低下抑制又は改善用組成物
CN115867289B (zh) * 2020-05-11 2026-04-14 三得利控股株式会社 含有nr及/或nmn与芝麻素类的组合物
CN113812618A (zh) * 2020-06-18 2021-12-21 陈信行 腐植酸芝麻素复方及其制程

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3001589B2 (ja) * 1989-07-21 2000-01-24 サントリー株式会社 リグナン類含有飲食物
EP0818196B1 (en) * 1989-07-21 2004-12-29 Suntory Limited Capsule, containing dioxabicyclo(3.3.0)octane compounds
US5211953A (en) * 1989-07-21 1993-05-18 Suntory, Limited Liver function improver
JP3075358B2 (ja) * 1990-04-03 2000-08-14 サントリー株式会社 肝機能改善剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
JPH08268887A (ja) * 1995-02-01 1996-10-15 Suntory Ltd 高血圧症又はそれに起因する医学的症状の予防又は改善剤
ES2202454T3 (es) * 1995-07-04 2004-04-01 Suntory Limited Uso de un agente equilibrante para acidos grasos insaturados omega-3 y omega-6.
JP3205315B2 (ja) * 1999-04-28 2001-09-04 リノール油脂株式会社 ジオキサビシクロ〔３．３．０〕オクタン誘導体を有効成分とする体脂肪低減剤
EP1250052A1 (en) * 2000-01-25 2002-10-23 Juvenon, Inc. Nutritional supplements for aged pets

Also Published As

Publication number Publication date
AU2005320579A1 (en) 2006-07-06
CA2592532A1 (en) 2006-07-06
AU2005320579B2 (en) 2011-09-22
TW200633696A (en) 2006-10-01
KR20070089752A (ko) 2007-08-31
CN1796388A (zh) 2006-07-05
EP1842540A1 (en) 2007-10-10
JPWO2006070856A1 (ja) 2008-06-12
WO2006070856A1 (ja) 2006-07-06
SG158183A1 (en) 2010-01-29
KR101244586B1 (ko) 2013-03-25
EP1842540A4 (en) 2011-12-28
CN101849935B (zh) 2011-09-28
HK1088333A1 (en) 2006-11-03
JP4995567B2 (ja) 2012-08-08
CN101849935A (zh) 2010-10-06
HK1148465A1 (en) 2011-09-09
CN1796388B (zh) 2011-01-26
US20080275110A1 (en) 2008-11-06
CA2592532C (en) 2015-02-17
TWI368506B (OSRAM) 2012-07-21

Similar Documents

Publication Publication Date Title
IL213564B (en) An antibody against vla-1, an in vitro method for determining the level of vla-1 in tissue, a pharmaceutical preparation containing an antibody against vla-1 and methods for treatment and diagnosis based on this antibody
PL1736160T3 (pl) Oligosacharydy alginianowe i ich pochodne oraz ich wytwarzanie i zastosowanie
WO2006015263A3 (en) Lonidamine analogs
AU2003223207A8 (en) Scds as modifiers of the p53 pathway and methods of use
IL220759A0 (en) 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO [4,5-d] PYRIMIDIN-2-ONE COMPOUNDS , PHARMACEUTICEL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE MANUFACTURE OF MESICAMENTS
IL181234A0 (en) Mixture of phytosterol ester(s) and 1,3-diglycerides(s) for use in the treatment of medical conditions
IL178012A0 (en) Diphenyl-indol-2-on compounds and their use in the treatment of cancer
ZA200409492B (en) Compositions and methods for the diagnosis and treatment of tumor.
AU2002308348A1 (en) Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
AU2003277164A8 (en) Imaging catheter with indicia and methods of use
ATE286664T1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
SG158183A1 (en) Sesamin/episesamin compositions
EP1534295A4 (en) FORMULATIONS AND METHODS OF ADMINISTRATION OF CEPHALOTAXINS, INCLUDING HOMOHARRINGTONIN
EE200300473A (et) Tsüano-asendatud dihüdropürimidiinühendid ja nende kasutamine haiguste raviks
IS6967A (is) Ný cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma
EP1750734A4 (en) PROCESS FOR THE PREPARATION AND USE OF FIBRINOLYTIC ENZYMES FOR THE TREATMENT OF DISEASES
IL173112A0 (en) Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids
IL176027A0 (en) Enoximone formulations and their use in the treatment of cardiac hypertrophy and heart failure
IL162941A0 (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
IL174594A (en) MANIPULATED NKT CELLS MODULATING THE Th1/Th2 BALANCE, USES AND THERAPEUTIC COMPOSITIONS THEREOF IN THE TREATMENT OF IMMUNE-RELATED DISORDERS
FR2827861B1 (fr) Derives des indazoles ou des indoles, leur utilisation en medecine humaine et plus particulierement en cancerologie
AU2003247112A8 (en) Use of hydrocolloids as prebiotic food ingredients and method of producing the same
PL354641A1 (en) Method of lowering the unfeed blood sugar level and increasing body weight with diabetics
PL1663101T3 (pl) Postać stosowana do doustnego podawania substancji czynnych, witamin i/lub substancji odżywczych, zestaw i zastosowanie
WO2003080568A3 (en) Probucol derivatives